Efficacy and tolerability of lumiracoxib 100mg once daily in knee osteoarthritis: a 13-week, randomized, double-blind study vs. placebo and celecoxib

OBJECTIVE: To determine the efficacy and safety of lumiracoxib for knee osteoarthritis (OA). METHODS: This was a 13-week, multicentre, randomized, double-blind, double-dummy, placebo-controlled study. Males or females aged >/= 18 years with primary knee OA received lumiracoxib 100 mg od, lumiraco...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Current medical research and opinion 2005-04, Vol.21 (4), p.517
Hauptverfasser:	Lehmann, Reiner, Brzosko, Marek, Kopsa, Petr, Nischik, Ruth
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!